GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Atf3
|
ENSMUSG00000026628.8 | activating transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Atf3 | mm10_v2_chr1_-_191183244_191183340 | -0.60 | 1.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_97417730 | 5.76 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr4_-_122961173 | 5.14 |
ENSMUST00000030408.5
ENSMUST00000127047.1 |
Mfsd2a
|
major facilitator superfamily domain containing 2A |
chr19_+_39510844 | 4.97 |
ENSMUST00000025968.4
|
Cyp2c39
|
cytochrome P450, family 2, subfamily c, polypeptide 39 |
chr4_-_62087261 | 4.39 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr9_-_48605147 | 4.34 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr3_-_81975742 | 4.33 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr11_-_120661175 | 4.31 |
ENSMUST00000150458.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr2_+_67748212 | 4.11 |
ENSMUST00000180887.1
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr17_+_79626669 | 3.97 |
ENSMUST00000086570.1
|
4921513D11Rik
|
RIKEN cDNA 4921513D11 gene |
chr12_-_103657095 | 3.75 |
ENSMUST00000152517.1
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr10_+_127866457 | 3.48 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr11_+_83709015 | 3.48 |
ENSMUST00000001009.7
|
Wfdc18
|
WAP four-disulfide core domain 18 |
chr17_-_34000257 | 3.36 |
ENSMUST00000087189.6
ENSMUST00000173075.1 ENSMUST00000172760.1 ENSMUST00000172912.1 ENSMUST00000025181.10 |
H2-K1
|
histocompatibility 2, K1, K region |
chr13_+_4436094 | 3.34 |
ENSMUST00000156277.1
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr9_-_57683644 | 3.21 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr1_+_127729405 | 3.20 |
ENSMUST00000038006.6
|
Acmsd
|
amino carboxymuconate semialdehyde decarboxylase |
chr1_-_139608282 | 3.18 |
ENSMUST00000170441.2
|
Cfhr3
|
complement factor H-related 3 |
chr12_-_103657159 | 3.17 |
ENSMUST00000044159.6
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr17_+_36942910 | 3.12 |
ENSMUST00000040498.5
|
Rnf39
|
ring finger protein 39 |
chr17_+_36943025 | 3.08 |
ENSMUST00000173072.1
|
Rnf39
|
ring finger protein 39 |
chr17_-_32917048 | 3.07 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr14_+_52824340 | 3.06 |
ENSMUST00000103648.2
|
Trav11d
|
T cell receptor alpha variable 11D |
chr9_+_44067072 | 3.04 |
ENSMUST00000177054.1
|
Usp2
|
ubiquitin specific peptidase 2 |
chr9_+_44066993 | 3.04 |
ENSMUST00000034508.7
|
Usp2
|
ubiquitin specific peptidase 2 |
chr19_-_40073731 | 3.04 |
ENSMUST00000048959.3
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr13_+_4434306 | 3.00 |
ENSMUST00000021630.8
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr7_-_14492926 | 2.99 |
ENSMUST00000108524.3
|
Sult2a7
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 7 |
chr5_-_87254804 | 2.98 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr2_+_155276297 | 2.91 |
ENSMUST00000029128.3
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha |
chr1_-_121332545 | 2.90 |
ENSMUST00000161068.1
|
Insig2
|
insulin induced gene 2 |
chr8_-_111630325 | 2.84 |
ENSMUST00000070004.3
|
Ldhd
|
lactate dehydrogenase D |
chr5_-_87091150 | 2.79 |
ENSMUST00000154455.1
|
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr19_-_4042165 | 2.79 |
ENSMUST00000042700.9
|
Gstp2
|
glutathione S-transferase, pi 2 |
chr1_-_13660476 | 2.79 |
ENSMUST00000027071.5
|
Lactb2
|
lactamase, beta 2 |
chr5_-_87591582 | 2.79 |
ENSMUST00000031201.7
|
Sult1e1
|
sulfotransferase family 1E, member 1 |
chr17_-_46487641 | 2.78 |
ENSMUST00000047034.8
|
Ttbk1
|
tau tubulin kinase 1 |
chr7_+_140763739 | 2.71 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr7_-_25539950 | 2.70 |
ENSMUST00000044547.8
|
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr10_-_24101951 | 2.70 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr19_-_8218832 | 2.68 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr13_-_23914998 | 2.67 |
ENSMUST00000021769.8
ENSMUST00000110407.2 |
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr4_+_115299046 | 2.67 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr5_-_87337165 | 2.66 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr15_-_98677451 | 2.63 |
ENSMUST00000120997.1
ENSMUST00000109149.2 ENSMUST00000003451.4 |
Rnd1
|
Rho family GTPase 1 |
chr19_+_12633303 | 2.61 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr19_-_44407703 | 2.52 |
ENSMUST00000041331.2
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr3_+_63295815 | 2.52 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chrX_-_140543177 | 2.52 |
ENSMUST00000055738.5
|
Tsc22d3
|
TSC22 domain family, member 3 |
chr18_-_3281036 | 2.51 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr4_-_105109829 | 2.51 |
ENSMUST00000030243.7
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr9_-_86695897 | 2.47 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr19_+_12633507 | 2.47 |
ENSMUST00000119960.1
|
Glyat
|
glycine-N-acyltransferase |
chr13_-_64274962 | 2.47 |
ENSMUST00000039318.8
|
Cdc14b
|
CDC14 cell division cycle 14B |
chr1_+_88095054 | 2.41 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr11_+_72435511 | 2.40 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr2_-_62412219 | 2.39 |
ENSMUST00000047812.7
|
Dpp4
|
dipeptidylpeptidase 4 |
chr11_+_72435534 | 2.39 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr8_-_24576297 | 2.38 |
ENSMUST00000033953.7
ENSMUST00000121992.1 |
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr2_+_162987330 | 2.35 |
ENSMUST00000018012.7
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr10_-_88504073 | 2.35 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr10_+_128971191 | 2.35 |
ENSMUST00000181142.1
|
9030616G12Rik
|
RIKEN cDNA 9030616G12 gene |
chr2_-_5676046 | 2.34 |
ENSMUST00000114987.3
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr11_+_72435565 | 2.34 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr7_-_48843663 | 2.34 |
ENSMUST00000167786.2
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr17_+_35320529 | 2.33 |
ENSMUST00000105041.3
ENSMUST00000073208.5 |
H2-Q1
|
histocompatibility 2, Q region locus 1 |
chr19_-_7802578 | 2.32 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr17_+_79614900 | 2.32 |
ENSMUST00000040368.2
|
Rmdn2
|
regulator of microtubule dynamics 2 |
chr5_-_87424201 | 2.30 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr12_-_104865076 | 2.28 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr7_-_73537621 | 2.27 |
ENSMUST00000172704.1
|
Chd2
|
chromodomain helicase DNA binding protein 2 |
chr19_-_59076069 | 2.25 |
ENSMUST00000047511.7
ENSMUST00000163821.1 |
4930506M07Rik
|
RIKEN cDNA 4930506M07 gene |
chr10_-_88503912 | 2.24 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr3_-_39359128 | 2.22 |
ENSMUST00000056409.2
|
Gm9845
|
predicted pseudogene 9845 |
chr3_-_108017877 | 2.21 |
ENSMUST00000004140.4
|
Gstm1
|
glutathione S-transferase, mu 1 |
chr7_-_44496406 | 2.20 |
ENSMUST00000118515.1
ENSMUST00000138328.1 ENSMUST00000008284.8 ENSMUST00000118808.1 |
Emc10
|
ER membrane protein complex subunit 10 |
chr5_+_9100681 | 2.18 |
ENSMUST00000115365.1
|
Tmem243
|
transmembrane protein 243, mitochondrial |
chr10_+_62071014 | 2.17 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr3_-_107986360 | 2.17 |
ENSMUST00000066530.6
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr6_+_41302265 | 2.16 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr7_+_140845562 | 2.16 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr11_-_78422217 | 2.15 |
ENSMUST00000001122.5
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr5_-_86926521 | 2.12 |
ENSMUST00000031183.2
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
chr4_+_42735545 | 2.12 |
ENSMUST00000068158.3
|
4930578G10Rik
|
RIKEN cDNA 4930578G10 gene |
chr11_-_3722189 | 2.12 |
ENSMUST00000102950.3
ENSMUST00000101632.3 |
Osbp2
|
oxysterol binding protein 2 |
chr9_-_45204083 | 2.10 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr9_-_50561261 | 2.10 |
ENSMUST00000034568.5
|
Tex12
|
testis expressed gene 12 |
chr15_-_84105662 | 2.08 |
ENSMUST00000082365.5
|
Sult4a1
|
sulfotransferase family 4A, member 1 |
chr7_+_19228334 | 2.08 |
ENSMUST00000063976.8
|
Opa3
|
optic atrophy 3 |
chr13_-_64274879 | 2.07 |
ENSMUST00000109770.1
|
Cdc14b
|
CDC14 cell division cycle 14B |
chr15_+_9335550 | 2.05 |
ENSMUST00000072403.6
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr10_-_41709297 | 2.03 |
ENSMUST00000019955.9
ENSMUST00000099932.3 |
Ccdc162
|
coiled-coil domain containing 162 |
chr7_+_27119909 | 2.03 |
ENSMUST00000003100.8
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr8_+_19194319 | 2.01 |
ENSMUST00000052601.3
|
Defb14
|
defensin beta 14 |
chr4_+_62360695 | 2.01 |
ENSMUST00000084526.5
|
Slc31a1
|
solute carrier family 31, member 1 |
chr1_-_91413163 | 1.99 |
ENSMUST00000086851.1
|
Hes6
|
hairy and enhancer of split 6 |
chr19_-_40187277 | 1.99 |
ENSMUST00000051846.6
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr9_-_70141484 | 1.99 |
ENSMUST00000034749.8
|
Fam81a
|
family with sequence similarity 81, member A |
chr5_-_137149320 | 1.98 |
ENSMUST00000041226.8
|
Muc3
|
mucin 3, intestinal |
chr2_+_25700039 | 1.96 |
ENSMUST00000077667.3
|
Obp2a
|
odorant binding protein 2A |
chr2_+_58755177 | 1.96 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr18_-_46728342 | 1.96 |
ENSMUST00000035804.7
|
Cdo1
|
cysteine dioxygenase 1, cytosolic |
chr4_-_117133953 | 1.95 |
ENSMUST00000076859.5
|
Plk3
|
polo-like kinase 3 |
chr3_+_118562129 | 1.95 |
ENSMUST00000039177.7
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr2_+_155382186 | 1.95 |
ENSMUST00000134218.1
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr3_+_81999461 | 1.92 |
ENSMUST00000107736.1
|
Asic5
|
acid-sensing (proton-gated) ion channel family member 5 |
chr6_+_129533183 | 1.92 |
ENSMUST00000032264.6
|
Gabarapl1
|
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
chr5_-_146009598 | 1.91 |
ENSMUST00000138870.1
ENSMUST00000068317.6 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr3_+_89459325 | 1.91 |
ENSMUST00000107410.1
|
Pmvk
|
phosphomevalonate kinase |
chr14_+_66635251 | 1.89 |
ENSMUST00000159365.1
ENSMUST00000054661.1 ENSMUST00000159068.1 |
Adra1a
|
adrenergic receptor, alpha 1a |
chr3_+_94693556 | 1.88 |
ENSMUST00000090848.3
ENSMUST00000173981.1 ENSMUST00000173849.1 ENSMUST00000174223.1 |
Selenbp2
|
selenium binding protein 2 |
chrX_+_36598199 | 1.88 |
ENSMUST00000073339.6
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr18_-_35627223 | 1.86 |
ENSMUST00000025212.5
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr19_+_7494033 | 1.85 |
ENSMUST00000170373.1
|
Atl3
|
atlastin GTPase 3 |
chr2_-_126783416 | 1.85 |
ENSMUST00000130356.1
ENSMUST00000028842.2 |
Usp50
|
ubiquitin specific peptidase 50 |
chr1_-_180193653 | 1.84 |
ENSMUST00000159914.1
|
Adck3
|
aarF domain containing kinase 3 |
chr17_-_31637135 | 1.80 |
ENSMUST00000118504.1
ENSMUST00000078509.5 ENSMUST00000067801.6 |
Cbs
|
cystathionine beta-synthase |
chrX_-_38456407 | 1.79 |
ENSMUST00000074913.5
ENSMUST00000016678.7 ENSMUST00000061755.8 |
Lamp2
|
lysosomal-associated membrane protein 2 |
chr18_-_12860197 | 1.77 |
ENSMUST00000124570.1
|
Osbpl1a
|
oxysterol binding protein-like 1A |
chr14_-_51922773 | 1.75 |
ENSMUST00000089771.2
|
Rnase13
|
ribonuclease, RNase A family, 13 (non-active) |
chr2_-_48457245 | 1.74 |
ENSMUST00000127672.1
|
Gm13481
|
predicted gene 13481 |
chr3_+_89459118 | 1.72 |
ENSMUST00000029564.5
|
Pmvk
|
phosphomevalonate kinase |
chr4_-_108118504 | 1.72 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr12_+_85288591 | 1.71 |
ENSMUST00000059341.4
|
Zc2hc1c
|
zinc finger, C2HC-type containing 1C |
chr7_+_26808880 | 1.70 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr17_+_73107982 | 1.70 |
ENSMUST00000130574.1
ENSMUST00000149064.1 ENSMUST00000067545.6 |
Lclat1
|
lysocardiolipin acyltransferase 1 |
chr5_+_87000838 | 1.69 |
ENSMUST00000031186.7
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr5_+_125389284 | 1.69 |
ENSMUST00000100700.2
|
Gm10382
|
predicted gene 10382 |
chr7_-_25539845 | 1.67 |
ENSMUST00000066503.7
ENSMUST00000064862.6 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr2_+_58754910 | 1.66 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr4_-_149307506 | 1.64 |
ENSMUST00000055647.8
ENSMUST00000030806.5 ENSMUST00000060537.6 |
Kif1b
|
kinesin family member 1B |
chr15_+_10249560 | 1.63 |
ENSMUST00000134410.1
|
Prlr
|
prolactin receptor |
chr1_+_152399824 | 1.63 |
ENSMUST00000044311.8
|
Colgalt2
|
collagen beta(1-O)galactosyltransferase 2 |
chr17_+_24736639 | 1.62 |
ENSMUST00000115262.1
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr1_+_24678536 | 1.62 |
ENSMUST00000095062.3
|
Lmbrd1
|
LMBR1 domain containing 1 |
chr5_-_92505518 | 1.62 |
ENSMUST00000031377.7
|
Scarb2
|
scavenger receptor class B, member 2 |
chr2_-_38926217 | 1.61 |
ENSMUST00000076275.4
ENSMUST00000142130.1 |
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1 |
chr1_+_4807823 | 1.61 |
ENSMUST00000027036.4
ENSMUST00000119612.2 ENSMUST00000137887.1 ENSMUST00000115529.1 ENSMUST00000150971.1 |
Lypla1
|
lysophospholipase 1 |
chr2_+_144556306 | 1.59 |
ENSMUST00000155876.1
ENSMUST00000149697.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr14_+_55560904 | 1.59 |
ENSMUST00000072530.4
ENSMUST00000128490.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr11_-_11898044 | 1.58 |
ENSMUST00000066237.3
|
Ddc
|
dopa decarboxylase |
chr15_+_25843264 | 1.57 |
ENSMUST00000022881.7
|
Fam134b
|
family with sequence similarity 134, member B |
chr1_-_121327776 | 1.57 |
ENSMUST00000160688.1
|
Insig2
|
insulin induced gene 2 |
chr5_-_145879857 | 1.57 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr7_-_72306595 | 1.56 |
ENSMUST00000079323.5
|
Mctp2
|
multiple C2 domains, transmembrane 2 |
chrX_-_56598069 | 1.56 |
ENSMUST00000059899.2
|
Mmgt1
|
membrane magnesium transporter 1 |
chr17_+_36958571 | 1.56 |
ENSMUST00000040177.6
|
Znrd1as
|
Znrd1 antisense |
chr14_+_123659971 | 1.56 |
ENSMUST00000049681.7
|
Itgbl1
|
integrin, beta-like 1 |
chr3_-_107986408 | 1.55 |
ENSMUST00000012348.2
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr5_-_45450143 | 1.55 |
ENSMUST00000154962.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chrX_-_74023745 | 1.55 |
ENSMUST00000114353.3
ENSMUST00000101458.2 |
Irak1
|
interleukin-1 receptor-associated kinase 1 |
chr6_-_113531575 | 1.55 |
ENSMUST00000032425.5
|
Emc3
|
ER membrane protein complex subunit 3 |
chr8_+_123235086 | 1.54 |
ENSMUST00000181432.1
|
4933417D19Rik
|
RIKEN cDNA 4933417D19 gene |
chr3_-_146596588 | 1.54 |
ENSMUST00000029836.4
|
Dnase2b
|
deoxyribonuclease II beta |
chr13_+_8885937 | 1.52 |
ENSMUST00000177397.1
ENSMUST00000177400.1 ENSMUST00000177447.1 |
Idi1
|
isopentenyl-diphosphate delta isomerase |
chr11_-_11898092 | 1.52 |
ENSMUST00000178704.1
|
Ddc
|
dopa decarboxylase |
chr1_-_162866502 | 1.51 |
ENSMUST00000046049.7
|
Fmo1
|
flavin containing monooxygenase 1 |
chr7_+_68275970 | 1.51 |
ENSMUST00000153805.1
|
Fam169b
|
family with sequence similarity 169, member B |
chr11_-_50931612 | 1.51 |
ENSMUST00000109124.3
|
Zfp354b
|
zinc finger protein 354B |
chr5_-_45450121 | 1.51 |
ENSMUST00000127562.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chr2_-_103485138 | 1.50 |
ENSMUST00000028610.3
|
Cat
|
catalase |
chr17_+_69969217 | 1.50 |
ENSMUST00000060072.5
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr11_-_71019233 | 1.49 |
ENSMUST00000108523.3
ENSMUST00000143850.1 |
Derl2
|
Der1-like domain family, member 2 |
chr2_+_144556229 | 1.49 |
ENSMUST00000143573.1
ENSMUST00000028916.8 ENSMUST00000155258.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr18_-_12819842 | 1.49 |
ENSMUST00000119043.1
|
Osbpl1a
|
oxysterol binding protein-like 1A |
chr8_-_93197799 | 1.49 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr3_+_94342092 | 1.49 |
ENSMUST00000029794.5
|
Them5
|
thioesterase superfamily member 5 |
chr19_+_43838803 | 1.48 |
ENSMUST00000099413.2
|
Gm10768
|
predicted gene 10768 |
chr5_-_123182704 | 1.48 |
ENSMUST00000154713.1
ENSMUST00000031398.7 |
Hpd
|
4-hydroxyphenylpyruvic acid dioxygenase |
chr7_-_127946725 | 1.48 |
ENSMUST00000118755.1
ENSMUST00000094026.3 |
Prss36
|
protease, serine, 36 |
chr10_-_128673896 | 1.48 |
ENSMUST00000054764.7
|
Suox
|
sulfite oxidase |
chr17_+_34836987 | 1.47 |
ENSMUST00000173874.1
ENSMUST00000046244.8 ENSMUST00000180043.1 |
Dxo
|
decapping exoribonuclease |
chr10_-_41587753 | 1.47 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr2_+_177508570 | 1.46 |
ENSMUST00000108940.2
|
Gm14403
|
predicted gene 14403 |
chr12_-_85288419 | 1.46 |
ENSMUST00000121930.1
|
Acyp1
|
acylphosphatase 1, erythrocyte (common) type |
chr7_+_119561699 | 1.46 |
ENSMUST00000167935.2
ENSMUST00000130583.1 |
Acsm2
|
acyl-CoA synthetase medium-chain family member 2 |
chr8_-_3748941 | 1.46 |
ENSMUST00000012847.1
|
Cd209a
|
CD209a antigen |
chr10_+_40629987 | 1.46 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr11_-_78165521 | 1.45 |
ENSMUST00000017530.3
|
Traf4
|
TNF receptor associated factor 4 |
chr2_-_32424005 | 1.44 |
ENSMUST00000113307.2
|
Slc25a25
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
chr3_+_94398517 | 1.44 |
ENSMUST00000050975.3
|
Lingo4
|
leucine rich repeat and Ig domain containing 4 |
chr17_+_25875492 | 1.44 |
ENSMUST00000026827.8
ENSMUST00000169308.1 ENSMUST00000169085.1 ENSMUST00000163356.1 |
0610011F06Rik
|
RIKEN cDNA 0610011F06 gene |
chr1_-_121327672 | 1.43 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr8_-_93229517 | 1.42 |
ENSMUST00000176282.1
ENSMUST00000034173.7 |
Ces1e
|
carboxylesterase 1E |
chr13_+_21312198 | 1.42 |
ENSMUST00000004453.7
|
Gpx6
|
glutathione peroxidase 6 |
chr13_-_23761223 | 1.42 |
ENSMUST00000102964.2
|
Hist1h4a
|
histone cluster 1, H4a |
chr9_-_71168657 | 1.41 |
ENSMUST00000113570.1
|
Aqp9
|
aquaporin 9 |
chr10_+_4710119 | 1.41 |
ENSMUST00000105588.1
ENSMUST00000105589.1 |
Esr1
|
estrogen receptor 1 (alpha) |
chr17_+_84683131 | 1.40 |
ENSMUST00000171915.1
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr19_-_11081088 | 1.40 |
ENSMUST00000025636.6
|
Ms4a8a
|
membrane-spanning 4-domains, subfamily A, member 8A |
chr11_+_115462464 | 1.40 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr17_-_78985428 | 1.40 |
ENSMUST00000118991.1
|
Prkd3
|
protein kinase D3 |
chr10_+_34297421 | 1.39 |
ENSMUST00000047935.6
|
Tspyl4
|
TSPY-like 4 |
chr11_-_116189542 | 1.39 |
ENSMUST00000148601.1
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr10_+_87521795 | 1.39 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr1_+_133363564 | 1.39 |
ENSMUST00000135222.2
|
Etnk2
|
ethanolamine kinase 2 |
chr8_-_27228581 | 1.39 |
ENSMUST00000121838.1
|
Adrb3
|
adrenergic receptor, beta 3 |
chr1_-_121332571 | 1.38 |
ENSMUST00000071064.6
|
Insig2
|
insulin induced gene 2 |
chr4_-_108118528 | 1.38 |
ENSMUST00000030340.8
|
Scp2
|
sterol carrier protein 2, liver |
chr17_-_31144271 | 1.38 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr17_-_32420965 | 1.37 |
ENSMUST00000170392.1
|
Pglyrp2
|
peptidoglycan recognition protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.7 | 5.1 | GO:0051977 | lysophospholipid transport(GO:0051977) |
1.5 | 4.4 | GO:0070347 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
1.4 | 4.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
1.4 | 2.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.4 | 4.3 | GO:0006507 | GPI anchor release(GO:0006507) |
1.1 | 3.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.1 | 3.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.0 | 4.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.0 | 3.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.0 | 2.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.9 | 4.7 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.9 | 2.6 | GO:0006571 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.9 | 2.6 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.8 | 2.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 2.4 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.8 | 3.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.8 | 2.3 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
0.8 | 3.1 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.8 | 4.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.8 | 0.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 2.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 2.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 3.6 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.7 | 2.8 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 2.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.6 | 12.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 3.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 2.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.9 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.6 | 7.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 2.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.6 | 1.8 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.6 | 1.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.6 | 4.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 5.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.5 | 3.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.5 | 2.7 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.5 | 3.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 2.0 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.5 | 2.0 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.5 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 2.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 0.5 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.5 | 1.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 0.5 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.5 | 1.4 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.5 | 2.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 1.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.4 | 1.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.4 | 1.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.4 | 13.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 1.6 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.4 | 2.4 | GO:0090005 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.4 | 2.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.4 | 1.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 2.4 | GO:0009074 | tryptophan catabolic process(GO:0006569) aromatic amino acid family catabolic process(GO:0009074) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.4 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.4 | 8.6 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.4 | 3.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 1.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 2.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.4 | 3.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 1.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.4 | 1.4 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.4 | 0.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 5.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 4.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 4.7 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 1.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 1.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.3 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.3 | 1.0 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 1.0 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.0 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 2.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.3 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.3 | 1.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 2.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 0.9 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.3 | 3.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 1.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 1.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.3 | 0.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.1 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 1.4 | GO:0060750 | prostate epithelial cord elongation(GO:0060523) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 1.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.3 | 2.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 0.8 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.3 | 1.4 | GO:0032827 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 3.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.3 | 1.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.8 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 3.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 0.8 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 7.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 1.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.3 | 1.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 1.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.8 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.3 | 1.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 2.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 2.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.7 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 | 1.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 2.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 2.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 6.0 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 3.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 2.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.9 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.2 | 0.7 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 1.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 1.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.7 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.2 | 2.7 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 2.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 3.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 0.7 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 2.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 6.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.9 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 1.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 1.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 3.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.8 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.2 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.6 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 2.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.4 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.2 | 1.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 2.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 3.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 1.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.2 | 0.6 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 1.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.2 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.5 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.4 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.2 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 1.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.2 | 0.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 0.5 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.9 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 1.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 1.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.5 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 0.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 1.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.5 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.2 | 1.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.6 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 1.7 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.2 | 0.2 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.2 | 0.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 2.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 2.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 1.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 2.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.7 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 1.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 2.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.6 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.4 | GO:0048352 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.4 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 0.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.1 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.5 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.1 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 2.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.5 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
0.1 | 1.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 1.0 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.3 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 1.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.7 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 3.1 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.4 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.1 | 0.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 1.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 2.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 1.8 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 2.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.1 | 0.9 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.1 | 0.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 4.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 1.3 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 2.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.5 | GO:0097491 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 0.6 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 3.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.3 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.1 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.8 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.5 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.9 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.9 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.9 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 1.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.3 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.3 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 3.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 1.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 2.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.1 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 1.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 1.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 2.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 4.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 3.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 2.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 2.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.3 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 0.9 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 0.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.9 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.1 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.6 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 1.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) monocyte homeostasis(GO:0035702) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.3 | GO:1904937 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.1 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.7 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.6 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.1 | 0.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.6 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 2.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.0 | 1.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 1.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.4 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.0 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.0 | 0.5 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.0 | 0.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.7 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.5 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.3 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 1.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 4.4 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.3 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 1.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 1.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0015881 | creatine transport(GO:0015881) |
0.0 | 0.5 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.8 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.0 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.7 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:1903537 | meiotic sister chromatid cohesion, centromeric(GO:0051754) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.0 | 0.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0046707 | ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.0 | 0.1 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.6 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.1 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 1.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 1.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.5 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.8 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.1 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0044818 | mitotic DNA replication checkpoint(GO:0033314) mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.7 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 2.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0071428 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.7 | GO:1903317 | regulation of protein processing(GO:0070613) regulation of protein maturation(GO:1903317) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.4 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.2 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:2001214 | negative regulation of vascular permeability(GO:0043116) positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.2 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 2.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.5 | GO:1904375 | regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.0 | 0.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.0 | GO:0042697 | menopause(GO:0042697) |
0.0 | 0.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 10.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.9 | 2.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.9 | 2.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.7 | 2.1 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.7 | 8.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 2.0 | GO:0036019 | endolysosome(GO:0036019) |
0.5 | 1.9 | GO:0097447 | dendritic tree(GO:0097447) |
0.5 | 3.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 1.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.4 | 5.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 7.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 1.3 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 2.2 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.9 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 2.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 8.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 2.3 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.3 | 1.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 0.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 0.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 1.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 3.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 3.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 1.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 2.4 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.2 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 2.1 | GO:0000801 | central element(GO:0000801) |
0.2 | 2.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.8 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.2 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 2.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 1.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.9 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 1.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 6.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.7 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.2 | 2.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.7 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 0.5 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 1.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 2.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 1.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.6 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.4 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 4.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.0 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 1.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 1.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.7 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 18.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.8 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 10.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 1.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 6.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.2 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.1 | 2.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 1.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 4.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 2.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 2.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) |
0.0 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 2.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 1.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.6 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 9.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 5.5 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 3.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 7.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 4.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0060473 | cortical granule(GO:0060473) |
0.0 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 25.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 3.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.7 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 2.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 2.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 1.3 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 1.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.7 | 6.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 8.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.3 | 4.0 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
1.3 | 5.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.0 | 4.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
1.0 | 4.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 3.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.9 | 2.8 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.9 | 4.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.9 | 3.5 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.8 | 2.5 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.8 | 4.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.8 | 3.1 | GO:0033814 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.8 | 3.1 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.8 | 3.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.7 | 3.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 1.9 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.6 | 2.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 1.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.6 | 1.9 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.6 | 8.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.6 | 1.8 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.6 | 1.8 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.6 | 2.4 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.6 | 2.4 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.6 | 2.9 | GO:2001070 | starch binding(GO:2001070) |
0.6 | 1.8 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.6 | 3.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.6 | 21.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.6 | 1.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.6 | 1.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
0.5 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 5.3 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 2.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 2.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.5 | 2.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.5 | 1.4 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.4 | 1.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.4 | 2.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 1.7 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.4 | 3.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 2.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 1.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 5.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 1.5 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 8.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 1.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.4 | 1.5 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.4 | 1.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.4 | 2.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.4 | 1.8 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.3 | 1.4 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.3 | 1.0 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.3 | 1.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.3 | 4.0 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 2.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 1.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.0 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.3 | 1.0 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 1.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 1.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 4.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 3.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 3.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 1.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 2.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 8.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 2.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 2.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.3 | 0.9 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.3 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 3.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 0.9 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.3 | 1.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 1.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 1.4 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.3 | 3.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.3 | 2.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.3 | 5.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.0 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.3 | 0.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 1.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 1.8 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.7 | GO:0030977 | taurine binding(GO:0030977) |
0.2 | 1.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 4.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.7 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.8 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.2 | 1.5 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 1.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.2 | 0.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 0.6 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.2 | 1.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.6 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.2 | 1.0 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.6 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.2 | 2.9 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 1.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 3.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 2.3 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0005118 | sevenless binding(GO:0005118) |
0.2 | 1.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 1.6 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 0.5 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.2 | 4.0 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 2.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.5 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.2 | 0.5 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.2 | 1.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.5 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
0.2 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.2 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 0.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 4.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 6.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 3.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 3.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.6 | GO:0051381 | histamine binding(GO:0051381) |
0.1 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 2.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.1 | 0.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.4 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.6 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 4.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 3.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.5 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 5.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0047237 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 2.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 4.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 1.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 2.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 2.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 2.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 4.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 3.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.2 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 3.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 2.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 2.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 3.6 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 6.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 3.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 1.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 7.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.4 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.1 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 1.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 1.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 1.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 1.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 2.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.0 | 0.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0099530 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.8 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 1.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.0 | 0.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 1.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.1 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.0 | 0.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 2.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
0.0 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 1.6 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 1.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 4.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 1.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0070002 | glutamic-type peptidase activity(GO:0070002) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 1.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 3.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.5 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 4.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 1.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 1.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.4 | GO:0003823 | antigen binding(GO:0003823) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 3.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 4.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 6.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 2.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 5.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 3.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 2.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 10.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 7.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 2.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 9.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 5.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 5.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 3.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 6.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 5.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 6.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 2.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 7.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 2.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 4.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 2.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 3.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 9.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 6.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 4.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 12.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 3.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.6 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 1.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 1.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |